KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $3.9 billion.

  • Merck's Cost of Revenue fell 551.47% to $3.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 billion, marking a year-over-year decrease of 404.53%. This contributed to the annual value of $15.2 billion for FY2024, which is 578.57% down from last year.
  • As of Q3 2025, Merck's Cost of Revenue stood at $3.9 billion, which was down 551.47% from $3.6 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Cost of Revenue registered a high of $5.4 billion during Q1 2022, and its lowest value of $3.1 billion during Q2 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $3.9 billion (2021), whereas its average is $3.9 billion.
  • Per our database at Business Quant, Merck's Cost of Revenue surged by 6817.76% in 2022 and then tumbled by 2702.6% in 2023.
  • Quarter analysis of 5 years shows Merck's Cost of Revenue stood at $3.9 billion in 2021, then rose by 0.18% to $3.9 billion in 2022, then increased by 0.8% to $3.9 billion in 2023, then dropped by 2.15% to $3.8 billion in 2024, then increased by 0.71% to $3.9 billion in 2025.
  • Its Cost of Revenue was $3.9 billion in Q3 2025, compared to $3.6 billion in Q2 2025 and $3.4 billion in Q1 2025.